Extent of Lymphadenectomy Does Not Predict Survival in Patients Treated with Primary Esophagectomy

Journal of Gastrointestinal Surgery

Volumn 17, Issue 9, 2013, Pages 1562-1569

  Wong, Joyce ^a   Weber, Jill ^a   Almhanna, Khaldoun ^a   Hoffe, Sarah ^a   Shridhar, Ravi ^a   Karl, Richard ^a   Meredith, Kenneth L ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Esophageal cancer; Lymphadenectomy; Survival

Indexed keywords

ADENOCARCINOMA; AGED; ARTICLE; DISEASE FREE SURVIVAL; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; EVALUATION STUDY; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE DISSECTION; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODE EXCISION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84883217560     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-013-2259-5     Document Type: Article

References (26)

1. American Cancer Society. Cancer facts & figures 2012. Atlanta: American Cancer Society; 2012.
2. Boshier PR, Anderson O, and Hanna GB. Transthoracic Versus Transhiatal Esophagectomy for the Treatment of Esophagogastric Cancer. A meta-analysis. Annals of Surgery, 2011; 254: 894-906.
3. Omloo JMT, Law SYK, Launois B, et al. Short and long-term advantages of transhiatal and transthoracic oesophageal cancer resection. EJSO, 2009; 35: 793-797.
4. Eloubeidi MA, Desmond R, Arguedas MR, et al. Prognostic factors for the survival of patients with esophageal carcinoma in the U. S.: the importance of tumor length and lymph node status. Cancer, 2002; 95(7): 1434-43.
5. Gertler R, Stein HJ, Langer R, et al. Long-term outcome of 2920 patients with canceres of the esophagus and esophagogastric junction: evaluation of the New Union Internationale Contre le Cancer/American Joint Cancer Committee staging system. Annals of Surgery, 2011; 253(4): 689-98.
6. AJCC (2010) Esophagus and esophagogastric junction. In: Edge SB, Byrd DR, Compton CC, et al. (eds). AJCC Cancer Staging Manual 7th edition. New York, NY: Springer, pp 103-11.
7. Hu Y, Hu C, Zhang H, et al. How does the number of resected lymph nodes influence TNM staging and prognosis for esophageal carcinoma? Annals of Surgical Oncology, 2010; 17: 784-790.
8. Yang HX, Xu Y, Fu JH, et al. An evaluation of the number of lymph nodes examined and survival for node-negative esophageal carcinoma: data from China. Annals of Surgical Oncology, 2010; 17: 1901-1911.
9. Schwarz RE and Smith DD. Clinical impact of lymphadenectomy extent in resectable esophageal cancer. Journal of Gastrointestinal Surgery, 2007; 11: 1384-1394.
10. Altorki NK, Zhou XK, Stiles B, et al. Total number of resected lymph nodes predicts survival in esophageal cancer. Annals of Surgery, 2008; 248(2): 221-226.
11. Greenstein AJ, Litle VR, Swanson SJ, et al. Prognostic significance of the number of lymph node metastases in esophageal cancer. Journal of the American College of Surgeons, 2008; 206(2): 239-46.
12. Mariette C, Piessen GP, Briez N, et al. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Annals of Surgery, 2008; 247(2): 365-371.
13. Kelty CJ, Kennedy CW, Falk GL. Ratio of metastatic lymph nodes to total number of nodes resected is prognostic for survival in esophageal carcinoma. Journal of Thoracic Oncology, 2010; 5: 1467-1471.
14. Groth SS, Virnig BA, Whitson BA, et al. Determination of the minimum number of lymph nodes to examine to maximize survival in patients with esophageal carcinoma: data from the Surveillance Epidemiology and End Results database. Journal of Thoracic and Cardiovascular Surgery, 2010; 139: 612-20.
15. Greenstein AJ, Litle VR, Swanson SJ, et al. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer. Cancer, 2008; 112: 1239-46.
16. Peyre CH, Hagen JA, DeMeester SR, et al. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Annals of Surgery, 2008; 248: 549-556.
17. Rizk NP, Ishwaran H, Rice TW, et al. Optimum lymphadenectomy for esophageal cancer. Annals of Surgery, 2010; 251: 46-50.
18. Rice TW, Rusch VW, Apperson-Hansen C, et al. Worldwide esophageal cancer collaboration. Diseases of the Esophagus, 2009; 22(1): 1-8.
19. Hulscher JB, van Sandick JW, De Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. New England Journal of Medicine, 2002; 347(21): 1662-9.
20. Omloo JM, Lagarde SM, Hulscher JB, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Annals of Surgery, 2007; 246(6): 992-1000.
21. Bollschweiler E, Besch S, Drebber U, et al. Influence of neoadjuvant chemoradiation on the number and size of analyzed lymph nodes in esophageal cancer. Annals of Surgical Oncology, 2010; 17: 3187-3194.
22. Vallbohmer D, Holscher AH, DeMeester S, et al. A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer. Annals of Surgery, 2010; 252: 744-749.
23. Meredith KL, Weber JM, Turaga KK, et al. Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer. Annals of Surgical Oncology, 21010; 17(4): 1159-67.
24. Tanaka T, Matono S, Nagano T, et al. Esophagectomy with extended lymphadenectomy for submucosal esophageal cancer: long-term outcomes and prognostic factors. Annals of Surgical Oncology, 2012; 19(3): 750-6.
25. Bogoevski D, Bockhorn M, Koenig A, et al. How radical should surgery be for early esophageal cancer? World Journal of Surgery, 2011; 35(6): 1311-20.
26. Grotenhuis BA, van Heijl M, Zehetner J, et al. Surgical management of submucosal esophageal cancer: extended or regional lymphadenectomy? Annals of Surgery, 2010; 252(5): 823-30.